subject area of
- Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV‐infected, therapy‐naïve patients: results of the EPIC study (CCR100136)* Journal Articles
-
Design, Synthesis, and Dopamine Receptor Modulating Activity of Diketopiperazine Peptidomimetics of
l -Prolyl-l -leucylglycinamide Journal Articles